These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34986538)

  • 21. Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors.
    Scavone JL; Mackie K; Van Bockstaele EJ
    Brain Res; 2010 Feb; 1312():18-31. PubMed ID: 19931229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoid modulation of limbic forebrain noradrenergic circuitry.
    Carvalho AF; Mackie K; Van Bockstaele EJ
    Eur J Neurosci; 2010 Jan; 31(2):286-301. PubMed ID: 20074224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low brain CB1 receptor occupancy by a second generation CB1 receptor antagonist TM38837 in comparison with rimonabant in nonhuman primates: a PET study.
    Takano A; Gulyás B; Varnäs K; Little PB; Noerregaard PK; Jensen NO; Elling CE; Halldin C
    Synapse; 2014 Mar; 68(3):89-97. PubMed ID: 24293119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorinated CRA13 analogues: Synthesis, in vitro evaluation, radiosynthesis, in silico and in vivo PET study.
    Hassan AHE; Park KT; Kim HJ; Lee HJ; Kwon YH; Hwang JY; Jang CG; Chung JH; Park KD; Lee SJ; Oh SJ; Lee YS
    Bioorg Chem; 2020 Jun; 99():103834. PubMed ID: 32334193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia.
    Zhuang Q; Dai C; Yang L; Wen H; Wang H; Jiang X; Zhang Y
    Cent Nerv Syst Agents Med Chem; 2017; 17(2):141-150. PubMed ID: 27142423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous and synthetic cannabinoids induce the downregulation of cannabinoid CB1 receptor in retina.
    Papadogkonaki S; Theodorakis Κ; Thermos K
    Exp Eye Res; 2019 Aug; 185():107694. PubMed ID: 31199905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence.
    Ceccarini J; Hompes T; Verhaeghen A; Casteels C; Peuskens H; Bormans G; Claes S; Van Laere K
    J Neurosci; 2014 Feb; 34(8):2822-31. PubMed ID: 24553924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
    Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
    Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis.
    Jacobson MR; Watts JJ; Boileau I; Tong J; Mizrahi R
    Eur Neuropsychopharmacol; 2019 Mar; 29(3):330-348. PubMed ID: 30635160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice.
    Morgan DJ; Davis BJ; Kearn CS; Marcus D; Cook AJ; Wager-Miller J; Straiker A; Myoga MH; Karduck J; Leishman E; Sim-Selley LJ; Czyzyk TA; Bradshaw HB; Selley DE; Mackie K
    J Neurosci; 2014 Apr; 34(15):5152-63. PubMed ID: 24719095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in Mice.
    Han X; Liang Y; Hempel B; Jordan CJ; Shen H; Bi GH; Li J; Xi ZX
    J Neurosci; 2023 Jan; 43(3):373-385. PubMed ID: 36517243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further evidence of anxiety- and depression-like behavior for total genetic ablation of cannabinoid receptor type 1.
    Soriano D; Brusco A; Caltana L
    Behav Brain Res; 2021 Feb; 400():113007. PubMed ID: 33171148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.
    Basavarajappa BS; Nixon RA; Arancio O
    Mini Rev Med Chem; 2009 Apr; 9(4):448-62. PubMed ID: 19356123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic exposure to cannabinoids before an emotional trauma may have negative effects on emotional function.
    Sbarski B; Akirav I
    Eur Neuropsychopharmacol; 2018 Aug; 28(8):955-969. PubMed ID: 30026011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: A pilot study.
    Chou S; Fish KN; Lewis DA; Sweet RA
    Neurobiol Dis; 2023 Sep; 185():106262. PubMed ID: 37586566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabis and Neuropsychiatric Disorders: An Updated Review.
    Chayasirisobhon S
    Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex.
    Lafourcade M; Elezgarai I; Mato S; Bakiri Y; Grandes P; Manzoni OJ
    PLoS One; 2007 Aug; 2(8):e709. PubMed ID: 17684555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cannabinoid system and microglia in health and disease.
    Duffy SS; Hayes JP; Fiore NT; Moalem-Taylor G
    Neuropharmacology; 2021 Jun; 190():108555. PubMed ID: 33845074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of presynaptic interaction between glucocorticoid and CB1 cannabinoid receptors in GABA- and glutamatergic terminals in the frontal cortex of laboratory rodents.
    Bitencourt RM; Alpár A; Cinquina V; Ferreira SG; Pinheiro BS; Lemos C; Ledent C; Takahashi RN; Sialana FJ; Lubec G; Cunha RA; Harkany T; Köfalvi A
    Neurochem Int; 2015 Nov; 90():72-84. PubMed ID: 26196379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.